Medication adherence and self-efficacy in patients on polypharmacy

Basit Öğe Kaydı
dc.contributor.authorÇetindağ Karatlı, Safiye Kübra
dc.contributor.authorKaratlı, Salih
dc.contributor.authorÖzkan Sevecan, Nurhayat
dc.contributor.authorKes, Duygu
dc.contributor.authorŞahin, Fadime
dc.date.accessioned2024-12-26T07:49:29Z
dc.date.available2024-12-26T07:49:29Z
dc.date.issued2024
dc.departmentFakülteler, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü
dc.description.abstractINTRODUCTION: Polypharmacy is defined as the use of multiple medications or the use of more medications than medically necessary, though there is no consensus on a precise definition. This study aimed to identify self-efficacy, treatment adherence, and the most influential factors affecting treatment adherence in patients with polypharmacy. METHODS: Patients using at least two medications were included in the study. A questionnaire, prepared based on a literature review, and the Medication Adherence Self-Efficacy Scale Short Form (MASES-SF) were administered to determine the patient's sociodemographic characteristics, disease status, types of medications used, and self-efficacy. RESULTS: The mean age of the 414 patients participating in the study was 59.9±11.8 years. Of the patients, 58.5% (n: 242) were female and 41.5% were male. There were significant differences in the mean scores of the Medication Adherence Self-Efficacy Scale based on the number of medications used and the number of chronic diseases. Patients using 2 medications had higher self-efficacy levels in medication adherence compared to those using 4 or more medications, and patients with 1 chronic disease had higher self-efficacy levels compared to those with 3 or more chronic diseases. Additionally, treatment adherence and self-efficacy were higher in males, patients with primary education, and those who visited doctors more frequently. DISCUSSION AND CONCLUSION: Identifying the factors that complicate treatment adherence in patients with multiple chronic diseases and high medication use, developing solutions to these problems, and increasing awareness among physicians can slow the progression of the disease and reduce the economic costs of adverse outcomes in our country.
dc.identifier.doi10.5505/amj.2024.34101
dc.identifier.endpage366
dc.identifier.issue4
dc.identifier.startpage356
dc.identifier.urihttps://hdl.handle.net/20.500.14619/14878 https://doi.org/10.5505/amj.2024.34101
dc.identifier.volume24
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofAnkara Medical Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectChronic disease
dc.subjectpolypharmacy
dc.subjecttreatment adherence
dc.subjectself-efficacy
dc.titleMedication adherence and self-efficacy in patients on polypharmacy
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
document (1).pdf
Boyut:
557.5 KB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Sağlık Bilimleri Fakültesi Koleksiyonu